Reports
Sale
Global Veterinary Vaccines Market Share, Size, Trends, Growth: By Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines, Other Vaccines; By Animal Type: Porcine, Others; By Route of Administration; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032
Global Veterinary Vaccines Market Outlook
The global veterinary vaccines market value was USD 10.73 billion in 2023, driven by the rising prevalence of zoonotic diseases structure across the globe. The market size is anticipated to grow at a CAGR of 6.2% during the forecast period of 2024-2032 to achieve a value of USD 18.43 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Veterinary vaccines are vaccines designed for animals to keep them protected from various diseases and infections. Domesticated animals and humans are in close proximity to each other which increases the chances of transfer of diseases which is why veterinary vaccines play a key role in maintaining the health of both animals and humans.
Many serious diseases such as epizootic disease are under control because of veterinary vaccines. They play a crucial role in restraining incurable diseases from spreading, due to which there is a steady demand for veterinary vaccines globally.
People worldwide are increasingly adopting pets, and are investing in their healthcare and immunisation which has fuelled the growth of the global veterinary vaccines market.
Raising livestock is a significant industry, particularly in regions with high meat consumption or export of meat. In such cases, veterinary vaccines are in high demand to ensure the health of the animal before slaughter.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on vaccine type, the market can be divided into livestock vaccines and companion animal vaccines, among others. Livestock vaccines are further divided into porcine vaccines, bovine vaccines, and poultry vaccines, among others, while companion animal vaccines are divided into canine vaccines, feline vaccines, and equine vaccines among others.
On the basis of route of administration, the market is divided into oral, parenteral, and others. By distributional channel, the market is segmented into veterinary hospitals and clinics, pharmacies and drug stores, and online, among others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global veterinary vaccines market covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Inc.
- Zoetis Services LLC
- Merck & Co., Inc.
- Ceva Santé Animale
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC
- Huvepharma Inc.
- Others
Market Share by Vaccine Type
With the robust meat industry and demand for animal-derived products, livestock are kept in large numbers in regions across the world. Ensuring adequate health of livestock is essential to prevent spread of disease and financial losses, due to which livestock handlers invest in veterinary vaccines. Accordingly, the livestock segment occupies a leading share of the global veterinary vaccines market.
As the popularity of pets grow and pet owners invest more financially into the well-being and health of companion animals, the demand for companion animal vaccines is expected to witness a steady rise in the coming years.
Market Share by Route of Administration
The parenteral route of administration of vaccines is the most common technique used, particularly for livestock. In this method, vaccines are injected directly into the skin or muscle of the animals. This process is speedy and efficient, with a leading share in the global veterinary vaccines market.
The oral route of administration is more common for companion animals and involves giving the animal vaccine either in the form of pills or suppositories that can be fed to the animal along with food. Although oral administration is less stressful for animals as compared to injections, and can also be given at home, providers need to be more careful to ensure the animal has swallowed the pill without spitting it out.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Boehringer Ingelheim International GmbH is a pharmaceutical company that is completely driven by research. It was established in 1885 and is headquartered in Germany. It is known for manufacturing and exporting healthcare products for animals and humans.
Elanco Animal Health Inc. founded in 1954 is headquartered in Indiana, United States. It is a pharmaceutical company producing medicines and a variety of vaccines for animals, including pets and animals owned by farmers.
Zoetis Services LLC is a healthcare company for animals founded in 1952. It has its headquarter in New Jersey, United States and believes in providing the consumers with medicines, vaccines, and diagnostic products of best quality.
Other market players include Merck & Co., Inc., Ceva Santé Animale, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, and Huvepharma Inc., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Animal Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Veterinary Vaccines Market Overview
3.1 Global Veterinary Vaccines Market Historical Value (2017-2023)
3.2 Global Veterinary Vaccines Market Forecast Value (2024-2032)
4 Global Veterinary Vaccines Market Landscape
4.1 Global Veterinary Vaccines Developers Landscape
4.1.0 Analysis by Year of Establishment
4.1.1 Analysis by Company Size
4.1.2 Analysis by Region
4.2 Global Veterinary Vaccines Product Landscape
4.2.0 Analysis by Type
4.2.1 Analysis by Animal Type
4.2.2 Analysis by End User
5 Global Veterinary Vaccines Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Veterinary Vaccines Market Segmentation
6.1 Global Veterinary Vaccines Market by Type
6.1.0 Market Overview
6.1.1 Live Attenuated Vaccines
6.1.2 Inactivated Vaccines
6.1.3 Toxoid Vaccines
6.1.4 DNA Vaccines
6.1.5 Recombinant Vaccines
6.1.6 Other Vaccines
6.2 Global Veterinary Vaccines Market by Animal Type
6.2.0 Market Overview
6.2.1 Porcine
6.2.2 Poultry
6.2.3 Livestock
6.2.3.1 Bovine
6.2.3.2 Small Ruminant
6.2.4 Companion Animal
6.2.4.1 Canine
6.2.4.2 Feline
6.2.5 Aquaculture
6.2.6 Others
6.3 Global Veterinary Vaccines Market by Route of Administration
6.3.0 Market Overview
6.3.1 Oral
6.3.2 Parenteral
6.3.3 Topical
6.4 Global Veterinary Vaccines Market by End User
6.4.0 Market Overview
6.4.1 Veterinary Hospitals
6.4.2 Veterinary Clinics
6.4.3 Poultry Farms
6.4.4 Animal Farms
6.4.5 Others
6.5 Global Veterinary Vaccines Market by Distribution Channel
6.5.0 Market Overview
6.5.1 Online Stores
6.5.2 Pharmacies and Drug Stores
6.5.3 Others
6.6 Global Veterinary Vaccines Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Veterinary Vaccines Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Veterinary Vaccines Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Veterinary Vaccines Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Veterinary Vaccines Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Veterinary Vaccines Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.0 US FDA
17.1.1 EU EMA
17.1.2 INDIA CDSCO
17.1.3 JAPAN PMDA
17.1.4 Others
18 Supplier Landscape
18.1 Bayer AG
18.1.0 Financial Analysis
18.1.1 Product Portfolio
18.1.2 Demographic Reach and Achievements
18.1.3 Mergers and Acquisitions
18.1.4 Certifications
18.2 Sanofi
18.2.0 Financial Analysis
18.2.1 Product Portfolio
18.2.2 Demographic Reach and Achievements
18.2.3 Mergers and Acquisitions
18.2.4 Certifications
18.3 Pfizer Inc.
18.3.0 Financial Analysis
18.3.1 Product Portfolio
18.3.2 Demographic Reach and Achievements
18.3.3 Mergers and Acquisitions
18.3.4 Certifications
18.4 GSK plc.
18.4.0 Financial Analysis
18.4.1 Product Portfolio
18.4.2 Demographic Reach and Achievements
18.4.3 Mergers and Acquisitions
18.4.4 Certifications
18.5 Merck & Co., Inc.
18.5.0 Financial Analysis
18.5.1 Product Portfolio
18.5.2 Demographic Reach and Achievements
18.5.3 Mergers and Acquisitions
18.5.4 Certifications
18.6 Ceva
18.6.0 Financial Analysis
18.6.1 Product Portfolio
18.6.2 Demographic Reach and Achievements
18.6.3 Mergers and Acquisitions
18.6.4 Certifications
18.7 Cargill, Incorporated
18.7.0 Financial Analysis
18.7.1 Product Portfolio
18.7.2 Demographic Reach and Achievements
18.7.3 Mergers and Acquisitions
18.7.4 Certifications
18.8 Boehringer Ingelheim International GmbH.
18.8.0 Financial Analysis
18.8.1 Product Portfolio
18.8.2 Demographic Reach and Achievements
18.8.3 Mergers and Acquisitions
18.8.4 Certifications
18.9 Takeda Pharmaceutical Company Limited
18.9.0 Financial Analysis
18.9.1 Product Portfolio
18.9.2 Demographic Reach and Achievements
18.9.3 Mergers and Acquisitions
18.9.4 Certifications
18.10 Zoetis
18.10.0 Financial Analysis
18.10.1 Product Portfolio
18.10.2 Demographic Reach and Achievements
18.10.3 Mergers and Acquisitions
18.10.4 Certifications
18.11 Dechra Pharmaceuticals PLC
18.11.0 Financial Analysis
18.11.1 Product Portfolio
18.11.2 Demographic Reach and Achievements
18.11.3 Mergers and Acquisitions
18.11.4 Certifications
18.12 Hester Biosciences Limited.
18.12.0 Financial Analysis
18.12.1 Product Portfolio
18.12.2 Demographic Reach and Achievements
18.12.3 Mergers and Acquisitions
18.12.4 Certifications
18.13 Elanco
18.13.0 Financial Analysis
18.13.1 Product Portfolio
18.13.2 Demographic Reach and Achievements
18.13.3 Mergers and Acquisitions
18.13.4 Certifications
18.14 Phibro Animal Health Corporation
18.14.0 Financial Analysis
18.14.1 Product Portfolio
18.14.2 Demographic Reach and Achievements
18.14.3 Mergers and Acquisitions
18.14.4 Certifications
18.15 Indovax
18.15.0 Financial Analysis
18.15.1 Product Portfolio
18.15.2 Demographic Reach and Achievements
18.15.3 Mergers and Acquisitions
18.15.4 Certifications
19 Global Veterinary Vaccines Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The Veterinary Vaccines Market was valued at USD 10.73 billion in 2023.
The market is expected to grow at a CAGR of 6.2% from 2024 to 2032 to reach a value of USD 18.43 billion by 2032.
The major market drivers are increase in awareness, developments in vaccines and technological advancements.
The key trends of the market are control of spread of serious diseases, adoption of pets, and increased inclination towards pet care.
Key market players include Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Zoetis Services LLC, Merck & Co., Inc., Ceva Santé Animale, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, and Huvepharma Inc., among others.
Veterinary vaccines are vaccines meant for animals to keep them protected from various diseases and infections.
The global veterinary vaccines market is segmented based on vaccine type, route of administration, distribution channel, and region.
The primary routes of administration in the market are oral and parenteral, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER